Anavex Life Sciences Corp (AVXL)

[sokol]

Except for AVXL and some other small cap stocks, the market is overvalued and overbought, and 2018's lower tax rates will provide the opportunity to take some profits in stocks that have had quite a run. A correction is likely to begin next week. Beginning in January 2018, we may see rotation to small cap stocks occur. AVXL may not participate immediately, but I am betting that it eventually will participate in the rotation to small cap stocks and momentum may be added as AVXL trials proceed. I see no valid reason to believe that trials will not eventually proceed. I am accustomed to delays, and I do not know of any good reason to be suspicious of the trial delays that have occurred. Frankly, I expected there would be trial delays based on my experiences in dealing with government agencies, including the FDA.